By Business/Source
Currency:USD
2026/Q1
Stock NameRevenueRatio
Parasiticides586M25.91%
Vaccines519M22.94%
Dermatology349M15.43%
Anti-infectives241M10.65%
Pain and sedation203M8.97%
Other pharmaceuticals158M6.98%
Animal health diagnostics117M5.17%
Other non-pharmaceuticals66M2.92%
Contract manufacturing & human health23M1.02%
View all
By Country/Region
Currency:USD
2025/FY
Stock NameRevenueRatio
United States (US)5.1B53.84%
Other1.02B10.73%
Other Emerging Markets913M9.64%
Other Developed Markets641M6.77%
Brazil393M4.15%
Australia329M3.48%
United Kingdom325M3.43%
Canada290M3.06%
Germany236M2.49%
China227M2.40%
View all